Use of the aspartate aminotransferase to platelet ratio index to follow liver fibrosis progression in infants with short gut

Richard S. Mangus, Michael G. O'Connor, A. Joseph Tector, Joel D. Lim, Rodrigo M. Vianna

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: Infants with parenteral nutrition dependence may develop liver dysfunction and progress to liver failure requiring transplantation. The aspartate aminotransferase-to-platelet ratio index (APRI) has good correlation with liver fibrosis progression in adults. This study applies APRI scoring to parenteral nutrition-dependant, short-gut infants to determine hepatic fibrosis progression. Methods: Laboratory values and biopsies were collected from initial intestinal resection (time 0) up to transplantation (end). Fibrosis scoring ranged from F0 (normal) to F4 (cirrhosis). Children were divided into 3 groups: (1) isolated intestine; and combined liver/intestine with gestational age (2) 34 weeks or greater and (3) 30 weeks or less. Liver function values over time, including calculated APRI, were analyzed as predictors of fibrosis. Results: Fifteen children who had 33 biopsies were included. Median APRI by fibrosis grade was F ≤ 2: 1.88, F3: 3.23, and F4: 14.16 (P < .01). Median APRI at transplant by study group was (1) isolated intestine: 2.47, (2) liver/intestine 35 weeks or longer EGA: 14.16, and (3) liver/intestine 30 weeks or less EGA: 14.74 (P = .04). Conclusion: Progression of APRI up to 60 days initially demonstrates similar values among study groups, but over time the score distinguishes those children with impending liver cirrhosis and differentiates fibrosis grade and study group.

Original languageEnglish (US)
Pages (from-to)1266-1273
Number of pages8
JournalJournal of pediatric surgery
Volume45
Issue number6
DOIs
StatePublished - Jun 2010

Fingerprint

Aspartate Aminotransferases
Liver Cirrhosis
Transaminases
Fibrosis
Blood Platelets
Intestines
Liver
Parenteral Nutrition
Transplantation
Biopsy
Liver Failure
Gestational Age
Liver Diseases
Transplants

Keywords

  • AST-to-platelet ratio index (APRI)
  • Hepatic fibrosis
  • Intestinal failure
  • Intestinal transplant
  • Short gut syndrome

ASJC Scopus subject areas

  • Surgery
  • Pediatrics, Perinatology, and Child Health
  • Medicine(all)

Cite this

Use of the aspartate aminotransferase to platelet ratio index to follow liver fibrosis progression in infants with short gut. / Mangus, Richard S.; O'Connor, Michael G.; Tector, A. Joseph; Lim, Joel D.; Vianna, Rodrigo M.

In: Journal of pediatric surgery, Vol. 45, No. 6, 06.2010, p. 1266-1273.

Research output: Contribution to journalArticle

Mangus, Richard S. ; O'Connor, Michael G. ; Tector, A. Joseph ; Lim, Joel D. ; Vianna, Rodrigo M. / Use of the aspartate aminotransferase to platelet ratio index to follow liver fibrosis progression in infants with short gut. In: Journal of pediatric surgery. 2010 ; Vol. 45, No. 6. pp. 1266-1273.
@article{25ca77c2d2b84a2289f0ae364edade24,
title = "Use of the aspartate aminotransferase to platelet ratio index to follow liver fibrosis progression in infants with short gut",
abstract = "Background: Infants with parenteral nutrition dependence may develop liver dysfunction and progress to liver failure requiring transplantation. The aspartate aminotransferase-to-platelet ratio index (APRI) has good correlation with liver fibrosis progression in adults. This study applies APRI scoring to parenteral nutrition-dependant, short-gut infants to determine hepatic fibrosis progression. Methods: Laboratory values and biopsies were collected from initial intestinal resection (time 0) up to transplantation (end). Fibrosis scoring ranged from F0 (normal) to F4 (cirrhosis). Children were divided into 3 groups: (1) isolated intestine; and combined liver/intestine with gestational age (2) 34 weeks or greater and (3) 30 weeks or less. Liver function values over time, including calculated APRI, were analyzed as predictors of fibrosis. Results: Fifteen children who had 33 biopsies were included. Median APRI by fibrosis grade was F ≤ 2: 1.88, F3: 3.23, and F4: 14.16 (P < .01). Median APRI at transplant by study group was (1) isolated intestine: 2.47, (2) liver/intestine 35 weeks or longer EGA: 14.16, and (3) liver/intestine 30 weeks or less EGA: 14.74 (P = .04). Conclusion: Progression of APRI up to 60 days initially demonstrates similar values among study groups, but over time the score distinguishes those children with impending liver cirrhosis and differentiates fibrosis grade and study group.",
keywords = "AST-to-platelet ratio index (APRI), Hepatic fibrosis, Intestinal failure, Intestinal transplant, Short gut syndrome",
author = "Mangus, {Richard S.} and O'Connor, {Michael G.} and Tector, {A. Joseph} and Lim, {Joel D.} and Vianna, {Rodrigo M.}",
year = "2010",
month = "6",
doi = "10.1016/j.jpedsurg.2010.02.098",
language = "English (US)",
volume = "45",
pages = "1266--1273",
journal = "Journal of Pediatric Surgery",
issn = "0022-3468",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Use of the aspartate aminotransferase to platelet ratio index to follow liver fibrosis progression in infants with short gut

AU - Mangus, Richard S.

AU - O'Connor, Michael G.

AU - Tector, A. Joseph

AU - Lim, Joel D.

AU - Vianna, Rodrigo M.

PY - 2010/6

Y1 - 2010/6

N2 - Background: Infants with parenteral nutrition dependence may develop liver dysfunction and progress to liver failure requiring transplantation. The aspartate aminotransferase-to-platelet ratio index (APRI) has good correlation with liver fibrosis progression in adults. This study applies APRI scoring to parenteral nutrition-dependant, short-gut infants to determine hepatic fibrosis progression. Methods: Laboratory values and biopsies were collected from initial intestinal resection (time 0) up to transplantation (end). Fibrosis scoring ranged from F0 (normal) to F4 (cirrhosis). Children were divided into 3 groups: (1) isolated intestine; and combined liver/intestine with gestational age (2) 34 weeks or greater and (3) 30 weeks or less. Liver function values over time, including calculated APRI, were analyzed as predictors of fibrosis. Results: Fifteen children who had 33 biopsies were included. Median APRI by fibrosis grade was F ≤ 2: 1.88, F3: 3.23, and F4: 14.16 (P < .01). Median APRI at transplant by study group was (1) isolated intestine: 2.47, (2) liver/intestine 35 weeks or longer EGA: 14.16, and (3) liver/intestine 30 weeks or less EGA: 14.74 (P = .04). Conclusion: Progression of APRI up to 60 days initially demonstrates similar values among study groups, but over time the score distinguishes those children with impending liver cirrhosis and differentiates fibrosis grade and study group.

AB - Background: Infants with parenteral nutrition dependence may develop liver dysfunction and progress to liver failure requiring transplantation. The aspartate aminotransferase-to-platelet ratio index (APRI) has good correlation with liver fibrosis progression in adults. This study applies APRI scoring to parenteral nutrition-dependant, short-gut infants to determine hepatic fibrosis progression. Methods: Laboratory values and biopsies were collected from initial intestinal resection (time 0) up to transplantation (end). Fibrosis scoring ranged from F0 (normal) to F4 (cirrhosis). Children were divided into 3 groups: (1) isolated intestine; and combined liver/intestine with gestational age (2) 34 weeks or greater and (3) 30 weeks or less. Liver function values over time, including calculated APRI, were analyzed as predictors of fibrosis. Results: Fifteen children who had 33 biopsies were included. Median APRI by fibrosis grade was F ≤ 2: 1.88, F3: 3.23, and F4: 14.16 (P < .01). Median APRI at transplant by study group was (1) isolated intestine: 2.47, (2) liver/intestine 35 weeks or longer EGA: 14.16, and (3) liver/intestine 30 weeks or less EGA: 14.74 (P = .04). Conclusion: Progression of APRI up to 60 days initially demonstrates similar values among study groups, but over time the score distinguishes those children with impending liver cirrhosis and differentiates fibrosis grade and study group.

KW - AST-to-platelet ratio index (APRI)

KW - Hepatic fibrosis

KW - Intestinal failure

KW - Intestinal transplant

KW - Short gut syndrome

UR - http://www.scopus.com/inward/record.url?scp=77953825171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953825171&partnerID=8YFLogxK

U2 - 10.1016/j.jpedsurg.2010.02.098

DO - 10.1016/j.jpedsurg.2010.02.098

M3 - Article

C2 - 20620330

AN - SCOPUS:77953825171

VL - 45

SP - 1266

EP - 1273

JO - Journal of Pediatric Surgery

JF - Journal of Pediatric Surgery

SN - 0022-3468

IS - 6

ER -